Despite their importance, the production of pharmaceutical intermediates is not without challenges. The increasing complexity of drug formulations necessitates a greater diversity of intermediates, which can strain existing manufacturing processes. Additionally, regulatory demands are ever-tightening, necessitating adherence to good manufacturing practices (GMP) and environmental considerations.